DNA Pharmaceuticals for Skin Diseases

DNA-Pharmaceuticals: Formulation and Delivery in Gene Therapy, DNA Vaccination and Immunotherapy

Volumn , Issue , 2006, Pages 173-187

  Alexeev, Vitali ^a   Uitto, Jouni ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

DNA pharmaceuticals; DNA vaccines; Epidermal powder immunization; Genetic immunization by jet injection; Physical methods of DNA delivery; Recombinant DNA based skin gene therapy; Skin diseases

Indexed keywords

EID: 84889796808     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/3527607536.ch10     Document Type: Chapter

References (58)

1. Verma, I. M.,Somia, N., Gene therapy-promises, problems and prospects. Nature 1997 389, 239-342
2. Mulligan, R. C.,The basic science of gene therapy. Science 1993 260, 926-932
3. Wolff, J. A.,Malone, R. W., Williams, P., et al., Direct gene transfer into mouse muscle in vivo. Science 1990 247, 1465-1468
4. Igoucheva, O.,Alexeev, V., Yoon, K., Oligonucleotide-directed mutagenesis and targeted gene correction: a mechanistic point of view. Curr. Mol. Med. 2004 4, 445-463
5. Kunzelmann, K.,Legendre, J. Y., Knoell, D. L., et al., Gene targeting of CFTR DNA in CF epithelial cells. Gene Ther. 1996 3, 859-867
6. Friedmann, T.,The evolving concept of gene therapy. Hum. Gene Ther. 1990 1, 175-181
7. Verma, I. M.,Naviaux, R. K., Human gene therapy. Curr. Opin. Genet Dev. 1991 1, 54-59
8. Jooss, K.,Chirmule, N., Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy. Gene Ther. 2003 10, 955-963
9. Li, S.,Huang, L., Nonviral gene therapy: promises and challenges. Gene Ther. 2000 7, 31-34
10. Choate, K. A.,Khavari, P. A., Direct cutaneous gene delivery in a human genetic skin disease. Hum Gene Ther. 1997 8, 1659-1665
11. Dellambra, E.,Vailly, J., Pellegrini, G., et al., Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa. Hum. Gene Ther. 1998 9, 1359-1370
12. Ghazizadeh, S.,Harrington, R., Taichman, L., In vivo transduction of mouse epidermis with recombinant retroviral vectors: implications for cutaneous gene therapy. Gene Ther. 1999 6, 1267-1275
13. Gambardella, L.,Barrandon, Y., The multifaceted adult epidermal stem cell. Curr. Opin. Cell Biol. 2003 15, 771-777
14. Lavker, R. M.,Sun, T. T., Oshima, H., et al., Hair follicle stem cells. J. Investig. Dermatol. Symp. Proc. 2003 8, 28-38
15. Ghazizadeh, S.,Taichman, L. B., Organization of stem cells and their progeny in human epidermis. J. Invest. Dermatol. 2005 124, 367-372
16. Freeman, S. M.,Abboud, C. N., Whartenby, K. A., et al., The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 1993 53, 5274-5283
17. Freeman, S. M.,Whartenby, K. A., Freeman, J. L., et al., In situ use of suicide genes for cancer therapy. Semin. Oncol. 1996 23, 31-45
18. Klatzmann, D.,Cherin, P., Bensimon, G., et al., A phase I/II doseescalation study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for metastatic melanoma.Study Group on Gene Therapy of Metastatic Melanoma. Hum. Gene Ther. 1998 9, 2585-2594
19. Cohen, J. L.,Boyer, O., Klatzmann, D., Suicide gene therapy of graftversus- host disease: immune reconstitution with transplanted mature T cells. Blood 2001 98, 2071-2076
20. Braunberger, E.,Cohen, J. L., Boyer, O., et al., T-Cell suicide gene therapy for organ transplantation: induction of long-lasting tolerance to allogeneic heart without generalized immunosuppression. Mol. Ther. 2000 2, 596-601
21. Greenhalgh, D. A.,Rothnagel, J. A., Roop, D. R., Epidermis: an attractive target tissue for gene therapy. J. Invest. Dermatol. 1994, 103, 63S-69S
22. Klinman, D. M.,Conover, J., Leiden, J. M., et al., Safe and effective regulation of hematocrit by gene gun administration of an erythropoietinencoding DNA plasmid. Hum. Gene Ther. 1999 10, 659-665
23. High, K. A.,Clinical gene transfer studies for hemophilia B. Semin. Thromb. Hemost. 2004 30, 257-267
24. Gomez-Vargas, A.,Hortelano, G., Nonviral gene therapy approaches to hemophilia. Semin. Thromb. Hemost. 2004 30, 197-204
25. Ulmer, J. B.,Donnelly, J. J., Parker, S. E., et al., Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993 259, 1745-1749
26. Doe, B.,Selby, M., Barnett, S., et al., Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. USA 1996 93, 8578-8583
27. Corr, M.,Lee, D. J., Carson, D. A., et al., Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 1996 184, 1555-1560
28. Houde, M.,Bertholet, S., Gagnon, E., et al., Phagosomes are competent organelles for antigen cross-presentation. Nature 2003 425, 402-406
29. Heath, W. R.,Belz, G. T., Behrens, G. M., et al., Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 2004 199, 9-26
30. Krieg, A. M.,From A to Z on CpG. Trends Immunol 2002 23, 64-65
31. Krieg, A. M.,A role for Toll in autoimmunity. Nat Immunol 2002 3, 423-424
32. Peachman, K. K.,Rao, M., Alving, C. R., Immunization with DNA through the skin. Methods 2003 31, 232-242
33. Schultze, J. L.,Maecker, B., von Bergwelt-Baildon, M. S., et al., Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens. Vox Sang. 2001 80, 81-89
34. Stevenson, F. K.,Rice, J., Zhu, D., Tumor vaccines. Adv. Immunol. 2004 82, 49-103
35. Talebi, T.,Weber, J. S., Peptide vaccine trials for melanoma: preclinical background and clinical results. Semin. Cancer Biol. 2003 13, 431-438
36. Klein, R. M.,Wolf, E. D., Wu, R., et al., High-velocity microprojectiles for delivering nucleic acids into living cells. Biotechnology 1992 24, 384-386
37. Wang, S.,Joshi, S., Lu, S., Delivery of DNA to skin by particle bombardment. In: Heiser, W. C. (Ed.), Methods Mol. Biol. Totowa, NJ, USA: Humana Press2004 245, 185-196
38. Lunn, D. P.,Soboll, G., Schram, B. R., et al., Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene. Vaccine 1999 17, 2245-2258
39. Macklin, M. D.,McCabe, D., McGregor, M. W., et al., Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus. J. Virol. 1998 72, 1491-1496
40. Haynes, J. R.,McCabe, D. E., Swain, W. F., et al., Particle-mediated nucleic acid immunization. J. Biotechnol. 1996 44, 37-42
41. Swain, W. F.,Macklin, M. D., Neumann, G., et al., Manipulation of immune responses via particle-mediated polynucleotide vaccines. Behring Inst. Mitt. 1997, 73-78
42. Tabata, Y.,Ikada, Y., Macrophage activation for antitumour function by muramyl dipeptide-protein conjugates. J. Pharm. Pharmacol. 1990 42, 13-19
43. Tabata, Y.,Uno, K., Yamaoka, T., et al., Effects of recombinant alpha-interferon- gelatin conjugate on in vivo murine tumor cell growth. Cancer Res. 1991 51, 5532-5538
44. Andrianov, A. K.,Payne, L. G., Polymeric carriers for oral uptake of microparticulates. Adv. Drug Deliv. Rev. 1998 34, 155-170
45. Evans, R. K.,Zhu, D. M., Casimiro, D. R., et al., Characterization and biological evaluation of a microparticle adjuvant formulation for plasmid DNA vaccines. J. Pharm. Sci. 2004 93, 1924-1939
46. Dale, C. J.,Liu, X. S., De Rose, R., et al., Chimeric human papilloma virus-simian/human immunodeficiency virus virus-like-particle vaccines: immunogenicity and protective efficacy in macaques. Virology 2002 301, 176-187
47. Liu, M.,Acres, B., Balloul, J. M., et al., Gene-based vaccines and immunotherapeutics. Proc. Natl. Acad. Sci. USA 2004, 101 SUPPL. 2, 14567-14571
48. Park, J.,Lee, S. H., Kim, A., Microparticle and liquid formulation of a novel HIV protease inhibitor. Pharm. Dev. Technol. 2002 7, 297-303
49. Jiang, W.,Gupta, R. K., Deshpande, M. C., et al., Biodegradable poly(lacticco- glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv. Drug Deliv. Rev. 2005 57, 391-410
50. Haensler, J.,Verdelet, C., Sanchez, V., et al., Intradermal DNA immunization by using jet-injectors in mice and monkeys. Vaccine 1999 17, 628-638
51. Ren, S.,Li, M., Smith, J. M., et al., Low-volume jet injection for intradermal immunization in rabbits. BMC Biotechnol. 2002, 2, 10
52. Anwer, K.,Earle, K. A., Shi, M., et al., Synergistic effect of formulated plasmid and needle-free injection for genetic vaccines. Pharm. Res. 1999 16, 889-895
53. Gramzinski, R. A.,Millan, C. L., Obaldia, N., et al., Immune response to a hepatitis B DNA vaccine in Aotus monkeys: a comparison of vaccine formulation, route, and method of administration. Mol. Med. 1998 4, 109-118
54. Parent Du Chatelet, I.,Lang, J., Schlumberger, M., et al., Clinical immunogenicity and tolerance studies of liquid vaccines delivered by jetinjector and a new single-use cartridge (Imule): comparison with standard syringe injection. Imule Investigators Group. Vaccine 1997 15, 449-458
55. Williams, J.,Fox-Leyva, L., Christensen, C., et al., Hepatitis A vaccine administration: comparison between jet-injector and needle injection. Vaccine 2000 18, 1939-1943
56. Jackson, L. A.,Austin, G., Chen, R. T., et al., Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors. Vaccine 2001 19, 4703-4709
57. Chen.,D., Burger, M., Chu, Q., et al., Epidermal powder immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity. Virus Res. 2004 103, 147-153
58. Dean, H. J.,Chen, D., Epidermal powder immunization against influenza. Vaccine 2004, 23, 681-686.